![]()
BRS5(FM2) - Microbial Metabolite Signalling Capacity
(Gut Bacteria Signals That Reach the Body)
Primary Mechanisms
- BRS5-FM2-PM4 — Microbial Substrate-Processing Selection & Adaptation
- BRS5-FM2-PM5 — SCFA Production & Signalling
- BRS5-FM2-PM6 — Polyphenol Biotransformation & Mitochondrial-Relevant Metabolite Generation
Key Constraints
- BRS5(KC1) — Fermentable Fibre Availability
- BRS5(KC2) — Polyphenol & Plant-Diversity Input Availability
1. Definition
A functional control point governing production of beneficial microbial metabolites that shape immune, endocrine, and neurobiological signalling.
- Drives microbial ecological turnover and competitive selection of beneficial functions.
- Produces short-chain fatty acids that influence barrier, inflammation, and brain signalling.
- Biotransforms polyphenols into mitochondrial-relevant metabolites such as urolithin A — Supporting BRS4.
2. Primary Biological Effects
↑ SCFA signalling; ↑ polyphenol biotransformation; ↑ metabolite-mediated gut-brain communication
4. Mechanistic Basis (Integrated FM Narrative)
4.1 Functional Rationale
Community substrate processing, SCFA signalling and polyphenol conversion contribute to producing biologically relevant microbial metabolites; diversity and turnover are not outcomes to maximise in themselves.
4.2 Evidence Summary
Defined-community experiments measure substrate competition and processing. In human dietary work, fibre increased processing-gene potential, while fermented foods increased diversity and reduced 19 circulating inflammatory proteins; these are distinct responses, not evidence that diversity caused the immune changes. SCFA studies and direct urolithin A interventions add downstream signalling and mitochondrial context. [1, 2, 7, 8, 9]
If processing and conversion capacities operate adequately, they would support metabolite output and its relevant host interactions. Functional potential is not measured metabolic output, and direct metabolite supplementation does not prove equivalent effects from its dietary precursors.
4.3 Suboptimal Function & Its Effects
Microbial metabolite signalling capacity may weaken when fermentable fibre availability, or polyphenol & plant-diversity input availability become inadequate, or when supporting biological pools are chronically strained.
Low fibre and low plant-diversity dietary patterns may reduce BRS5(KC1) — Fermentable Fibre Availability. Ultra-processed diets displacing fermentable whole-food substrates may further strain pool availability, repeated low-intake of resistant starch and soluble fibre classes, erratic meal patterns reducing consistent microbial substrate delivery, while inflammatory or metabolic burden increasing ecological instability.
Low plant diversity over time may reduce BRS5(KC2) — Polyphenol & Plant-Diversity Input Availability. Low polyphenol density in the diet may further strain pool availability, repetitive ultra-processed food patterns with narrow botanical exposure, lack of herbs, spices, legumes, and whole grains, while ecological monotony reducing microbial redundancy.
These pressures may impair BRS5-FM2-PM4 — Microbial Substrate-Processing Selection & Adaptation, weaken BRS5-FM2-PM5 — SCFA Production & Signalling, and reduce the effectiveness of BRS5-FM2-PM6 — Polyphenol Biotransformation & Mitochondrial-Relevant Metabolite Generation. At the FM level, this may shift BRS5(FM2) toward reduced microbial metabolite signalling capacity performance.
5. Connected Mechanisms
- BRS3-FM1-PM2 - Gut-Derived Inflammatory Signalling — biological connection relevant to this mechanism
- BRS4-FM1-PM1 - Electron Transport Chain Function — biological connection relevant to this mechanism
- BRS-X(Circadian-FM1-PM2) — Feeding-Time Circadian Synchronisation — feeding time can shift peripheral clocks; substrate studies here do not establish that synchronisation
7. Phenome Connections
These outcomes describe translational contexts for the FM as an integrated biological capacity. They are not single-mechanism treatment claims. FM confidence uplift: FM confidence may exceed that of any individual child PM only where multiple PMs converge on the same phenome and the integrated FM biology provides additional biological rationale (biological uplift) beyond the individual mechanisms.
Each Phenome relationship has two independent ratings. They are not combined or averaged.
Biology → Phenome Relationship Strength
How direct and important is this biological mechanism expected to be to the Phenome within the BRAIN model?
Evidence Confidence
How strongly does the adjudicated evidence support this particular biology → Phenome relationship?
- Biology → Phenome Relationship Strength: Low–Medium
- Evidence Confidence: Low–Medium
- Synthesis: Microbial ecological turnover and SCFA production jointly generate metabolite signals that can support attention-relevant gut–brain communication when fermentable substrate patterns are adequate. Human microbiome disruption and SCFA-signalling reviews support low–medium biological relevance without claiming fibre or metabolite interventions treat ADHD.
- Key References:
- Biology → Phenome Relationship Strength: Low
- Evidence Confidence: Low
- Synthesis: Ecological substrate processing and polyphenol biotransformation generate microbial metabolites that can support mitochondrial-relevant signalling context for cognitive clarity. Current ADHD-linked evidence remains largely associative, so confidence stays low pending stronger mechanism–phenome bridging.
- Key References:
- Biology → Phenome Relationship Strength: Low
- Evidence Confidence: Low
- Synthesis: SCFA signalling contributes to gut–brain metabolite tone that may indirectly influence emotional regulation pathways. Attached evidence is limited and translational, so Biology → Phenome and Evidence Confidence remain low at this integrated FM level.
- Key References:
8. References
- [1] Wastyk et al. (2021) — Gut-microbiota-targeted Diets Modulate Human Immune Status
- [2] Andreux et al. (2019) — Mitophagy Activator Urolithin a Is Safe and Induces a Molecular Signature
- [3] Singh et al. (2022) — Direct Supplementation with Urolithin a Overcomes Limitations of Dietary Exposure and Gut
- [4] Steckler et al. (2024) — Dysbiosis and Decreased Short-chain Fatty Acids
- [5] Prehn-Kristensen et al. (2018) — Reduced Microbiome Alpha Diversity in Young Patients with ADHD
- [6] Schleupner and Carmichael (2022) — Closing Research Gaps Through Female Inclusion in Study Design
- [7] Patnode et al. (2019) — Interspecies Competition Impacts Targeted Manipulation of Human Gut Bacteria by Fiber-Derived Glycans
- [8] Silva et al. (2020) — Role of Short-Chain Fatty Acids from Gut Microbiota in Gut-Brain Communication
- [9] Hoyles et al. (2018) — Protective Effects of Propionate Upon the Blood-brain Barrier